| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Soft Tissue Neoplasms | 20 | 2021 | 1356 | 4.470 |
Why?
|
| Sarcoma | 14 | 2020 | 1878 | 2.830 |
Why?
|
| Neoplasms, Radiation-Induced | 4 | 2020 | 566 | 1.750 |
Why?
|
| Gastrointestinal Neoplasms | 7 | 2020 | 986 | 1.390 |
Why?
|
| Immunohistochemistry | 25 | 2022 | 11689 | 1.370 |
Why?
|
| Histiocytoma, Benign Fibrous | 4 | 2015 | 110 | 1.230 |
Why?
|
| Fibrosarcoma | 3 | 2013 | 350 | 1.160 |
Why?
|
| Skin Neoplasms | 11 | 2022 | 5318 | 1.090 |
Why?
|
| Solitary Fibrous Tumors | 3 | 2014 | 73 | 1.040 |
Why?
|
| Nevus, Blue | 2 | 2022 | 36 | 1.030 |
Why?
|
| STAT6 Transcription Factor | 2 | 2014 | 207 | 0.960 |
Why?
|
| Carney Complex | 1 | 2022 | 12 | 0.940 |
Why?
|
| Succinate Dehydrogenase | 3 | 2017 | 156 | 0.930 |
Why?
|
| Carcinoma | 3 | 2020 | 2321 | 0.900 |
Why?
|
| Mucin-4 | 2 | 2012 | 39 | 0.890 |
Why?
|
| Myxoma | 1 | 2022 | 127 | 0.870 |
Why?
|
| Epithelioid Cells | 3 | 2019 | 74 | 0.820 |
Why?
|
| Leiomyosarcoma | 3 | 2022 | 458 | 0.780 |
Why?
|
| Gastrointestinal Stromal Tumors | 4 | 2017 | 665 | 0.770 |
Why?
|
| Gene Rearrangement | 3 | 2015 | 1202 | 0.760 |
Why?
|
| World Health Organization | 3 | 2021 | 1286 | 0.710 |
Why?
|
| Diagnosis, Differential | 16 | 2020 | 13217 | 0.700 |
Why?
|
| Smad4 Protein | 1 | 2019 | 166 | 0.690 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 2 | 2018 | 194 | 0.670 |
Why?
|
| Proto-Oncogene Proteins c-kit | 5 | 2017 | 784 | 0.660 |
Why?
|
| Fumarate Hydratase | 1 | 2017 | 47 | 0.640 |
Why?
|
| Carcinoid Tumor | 2 | 2018 | 234 | 0.610 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2017 | 87 | 0.610 |
Why?
|
| Bone Neoplasms | 3 | 2021 | 2578 | 0.600 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2019 | 225 | 0.600 |
Why?
|
| Mast Cells | 2 | 2014 | 1596 | 0.580 |
Why?
|
| DNA Mismatch Repair | 1 | 2019 | 408 | 0.560 |
Why?
|
| Liposarcoma | 2 | 2019 | 316 | 0.560 |
Why?
|
| Hemangioendothelioma, Epithelioid | 1 | 2016 | 54 | 0.550 |
Why?
|
| Terminology as Topic | 3 | 2019 | 1612 | 0.550 |
Why?
|
| Pancreatic Neoplasms | 8 | 2019 | 4980 | 0.550 |
Why?
|
| Histiocytoma, Malignant Fibrous | 2 | 2014 | 59 | 0.540 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 987 | 0.520 |
Why?
|
| Calmodulin-Binding Proteins | 2 | 2022 | 259 | 0.490 |
Why?
|
| Sclerosis | 2 | 2019 | 199 | 0.490 |
Why?
|
| Hemangioblastoma | 1 | 2014 | 68 | 0.490 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 1 | 2013 | 68 | 0.470 |
Why?
|
| Mastocytosis, Systemic | 1 | 2014 | 96 | 0.460 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2012 | 66 | 0.450 |
Why?
|
| Mastocytosis | 1 | 2014 | 151 | 0.440 |
Why?
|
| Thoracic Neoplasms | 1 | 2013 | 265 | 0.410 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 1090 | 0.400 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 539 | 0.400 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 1634 | 0.400 |
Why?
|
| Carcinoma, Pancreatic Ductal | 5 | 2019 | 1510 | 0.400 |
Why?
|
| Mediastinal Neoplasms | 1 | 2014 | 440 | 0.390 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2015 | 1633 | 0.390 |
Why?
|
| Stomach | 1 | 2014 | 670 | 0.370 |
Why?
|
| Cell Nucleus | 2 | 2016 | 2995 | 0.360 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2011 | 144 | 0.360 |
Why?
|
| Gene Amplification | 1 | 2014 | 1078 | 0.360 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2014 | 419 | 0.350 |
Why?
|
| Neoplasm Proteins | 3 | 2018 | 3741 | 0.350 |
Why?
|
| Smooth Muscle Tumor | 2 | 2020 | 66 | 0.340 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2015 | 2648 | 0.330 |
Why?
|
| Trans-Activators | 2 | 2016 | 3047 | 0.330 |
Why?
|
| Melanoma | 3 | 2022 | 5250 | 0.330 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2020 | 3689 | 0.320 |
Why?
|
| Blood Vessels | 1 | 2014 | 1154 | 0.320 |
Why?
|
| Testicular Neoplasms | 1 | 2014 | 767 | 0.320 |
Why?
|
| Chromosome Aberrations | 1 | 2014 | 1808 | 0.320 |
Why?
|
| Mitosis | 3 | 2022 | 1248 | 0.320 |
Why?
|
| Alopecia | 1 | 2011 | 367 | 0.310 |
Why?
|
| Humans | 71 | 2022 | 715777 | 0.310 |
Why?
|
| Adult | 37 | 2022 | 212266 | 0.310 |
Why?
|
| Prognosis | 10 | 2020 | 29005 | 0.310 |
Why?
|
| Mucin-1 | 1 | 2011 | 532 | 0.300 |
Why?
|
| Eosinophils | 1 | 2011 | 935 | 0.290 |
Why?
|
| Antibodies, Monoclonal | 2 | 2015 | 9548 | 0.280 |
Why?
|
| Gastrointestinal Diseases | 1 | 2014 | 1156 | 0.280 |
Why?
|
| Keratin-17 | 2 | 2016 | 26 | 0.280 |
Why?
|
| Biopsy | 7 | 2018 | 6736 | 0.270 |
Why?
|
| Mutation | 9 | 2022 | 29291 | 0.270 |
Why?
|
| Middle Aged | 35 | 2022 | 214639 | 0.260 |
Why?
|
| Genomics | 2 | 2018 | 5342 | 0.260 |
Why?
|
| Male | 41 | 2022 | 350324 | 0.260 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2019 | 8896 | 0.260 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 1888 | 0.250 |
Why?
|
| Hemangiosarcoma | 2 | 2019 | 222 | 0.250 |
Why?
|
| Predictive Value of Tests | 8 | 2018 | 15199 | 0.240 |
Why?
|
| Aged | 29 | 2022 | 162448 | 0.240 |
Why?
|
| Kidney Neoplasms | 3 | 2015 | 4018 | 0.240 |
Why?
|
| Stomach Neoplasms | 1 | 2012 | 1245 | 0.230 |
Why?
|
| Anus Neoplasms | 3 | 2015 | 295 | 0.230 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3034 | 0.230 |
Why?
|
| Female | 40 | 2022 | 377204 | 0.220 |
Why?
|
| Glomus Tumor | 1 | 2022 | 61 | 0.220 |
Why?
|
| Young Adult | 13 | 2022 | 56226 | 0.210 |
Why?
|
| Aged, 80 and over | 14 | 2022 | 58323 | 0.210 |
Why?
|
| MART-1 Antigen | 1 | 2020 | 78 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 1785 | 0.200 |
Why?
|
| Skin | 1 | 2014 | 4298 | 0.200 |
Why?
|
| Adenocarcinoma | 5 | 2018 | 6324 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 4561 | 0.190 |
Why?
|
| S100 Proteins | 1 | 2020 | 260 | 0.190 |
Why?
|
| Uveal Neoplasms | 1 | 2022 | 307 | 0.190 |
Why?
|
| Liver | 1 | 2015 | 7594 | 0.180 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 6592 | 0.180 |
Why?
|
| Cystadenoma, Serous | 1 | 2019 | 100 | 0.180 |
Why?
|
| Histones | 2 | 2020 | 2551 | 0.170 |
Why?
|
| Nevus, Pigmented | 1 | 2020 | 216 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7446 | 0.170 |
Why?
|
| Breast Neoplasms | 3 | 2022 | 20062 | 0.170 |
Why?
|
| Methylation | 1 | 2020 | 1097 | 0.160 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 8805 | 0.160 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2020 | 435 | 0.160 |
Why?
|
| Gene Expression | 4 | 2022 | 7954 | 0.150 |
Why?
|
| Melanocytes | 1 | 2020 | 521 | 0.150 |
Why?
|
| Appendiceal Neoplasms | 1 | 2018 | 118 | 0.150 |
Why?
|
| Adolescent | 10 | 2022 | 85155 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 8571 | 0.150 |
Why?
|
| Buttocks | 1 | 2016 | 115 | 0.150 |
Why?
|
| Neurilemmoma | 2 | 2020 | 524 | 0.140 |
Why?
|
| Pancreatic Cyst | 1 | 2019 | 351 | 0.140 |
Why?
|
| Anal Canal | 2 | 2015 | 345 | 0.140 |
Why?
|
| Goblet Cells | 1 | 2018 | 268 | 0.140 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2015 | 68 | 0.140 |
Why?
|
| Heart Neoplasms | 1 | 2019 | 382 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2015 | 3994 | 0.140 |
Why?
|
| Protein Kinase C-delta | 1 | 2015 | 133 | 0.130 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2019 | 374 | 0.130 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2015 | 82 | 0.130 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 2 | 2017 | 356 | 0.130 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2015 | 105 | 0.130 |
Why?
|
| Oncogenes | 1 | 2020 | 1246 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 321 | 0.130 |
Why?
|
| Germ Cells | 1 | 2018 | 587 | 0.130 |
Why?
|
| DNA Methylation | 2 | 2019 | 4078 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2021 | 1566 | 0.130 |
Why?
|
| Forearm | 1 | 2016 | 406 | 0.130 |
Why?
|
| Lipoma | 1 | 2016 | 332 | 0.130 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2015 | 148 | 0.130 |
Why?
|
| Liver Function Tests | 1 | 2015 | 534 | 0.120 |
Why?
|
| Mitotic Index | 1 | 2014 | 173 | 0.120 |
Why?
|
| Genetic Markers | 1 | 2020 | 2688 | 0.120 |
Why?
|
| Stromal Cells | 1 | 2019 | 1338 | 0.120 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2015 | 194 | 0.120 |
Why?
|
| Child | 8 | 2019 | 74468 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 728 | 0.120 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 476 | 0.120 |
Why?
|
| Genital Neoplasms, Female | 1 | 2019 | 517 | 0.120 |
Why?
|
| Osteosarcoma | 1 | 2019 | 890 | 0.120 |
Why?
|
| Survival Rate | 3 | 2019 | 13206 | 0.120 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2014 | 313 | 0.120 |
Why?
|
| Electron Transport Complex II | 1 | 2012 | 51 | 0.120 |
Why?
|
| Foot | 1 | 2016 | 509 | 0.120 |
Why?
|
| Precancerous Conditions | 1 | 2019 | 946 | 0.120 |
Why?
|
| Tryptases | 1 | 2014 | 201 | 0.120 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2014 | 156 | 0.110 |
Why?
|
| Neoplasm, Residual | 2 | 2017 | 986 | 0.110 |
Why?
|
| DNA Copy Number Variations | 2 | 2017 | 1894 | 0.110 |
Why?
|
| Gene Expression Profiling | 4 | 2018 | 9504 | 0.110 |
Why?
|
| Neoplasms, Second Primary | 1 | 2020 | 1010 | 0.110 |
Why?
|
| Lung Neoplasms | 2 | 2014 | 12539 | 0.110 |
Why?
|
| Gene Fusion | 1 | 2015 | 371 | 0.110 |
Why?
|
| Receptors, AMPA | 1 | 2014 | 343 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 13626 | 0.110 |
Why?
|
| Lymphatic Metastasis | 3 | 2017 | 2968 | 0.110 |
Why?
|
| Lymph Node Excision | 1 | 2017 | 1192 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 3 | 2015 | 3681 | 0.100 |
Why?
|
| Leg | 1 | 2016 | 1115 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 380 | 0.100 |
Why?
|
| Radiotherapy | 1 | 2019 | 1614 | 0.100 |
Why?
|
| Erdheim-Chester Disease | 1 | 2010 | 12 | 0.100 |
Why?
|
| Cervix Uteri | 1 | 2015 | 578 | 0.100 |
Why?
|
| Dyspnea | 1 | 2019 | 1253 | 0.100 |
Why?
|
| Sarcoma, Synovial | 1 | 2012 | 167 | 0.100 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 568 | 0.100 |
Why?
|
| Carcinoma in Situ | 2 | 2015 | 823 | 0.100 |
Why?
|
| Gastric Mucosa | 1 | 2014 | 599 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 6722 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15079 | 0.100 |
Why?
|
| Appendectomy | 1 | 2013 | 387 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2014 | 521 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 4 | 2022 | 2016 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1373 | 0.100 |
Why?
|
| Sensitivity and Specificity | 3 | 2019 | 14902 | 0.090 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2013 | 485 | 0.090 |
Why?
|
| Lymphoma | 1 | 2019 | 1881 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 2883 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4893 | 0.090 |
Why?
|
| Cell Count | 1 | 2014 | 1912 | 0.090 |
Why?
|
| Remission Induction | 1 | 2015 | 2394 | 0.090 |
Why?
|
| Ovarian Neoplasms | 2 | 2018 | 4751 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 5074 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2018 | 2594 | 0.090 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2015 | 2955 | 0.090 |
Why?
|
| Mesothelioma | 1 | 2015 | 816 | 0.090 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 509 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2018 | 10499 | 0.080 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2012 | 624 | 0.080 |
Why?
|
| Rare Diseases | 1 | 2013 | 530 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2019 | 62004 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2014 | 1900 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 2 | 2019 | 2719 | 0.080 |
Why?
|
| Rectal Neoplasms | 1 | 2015 | 1121 | 0.080 |
Why?
|
| Papillomavirus Infections | 2 | 2015 | 1513 | 0.080 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 1454 | 0.080 |
Why?
|
| DNA, Neoplasm | 1 | 2012 | 1773 | 0.080 |
Why?
|
| Diarrhea | 1 | 2014 | 1372 | 0.080 |
Why?
|
| Disease Progression | 3 | 2020 | 13215 | 0.070 |
Why?
|
| Colonoscopy | 1 | 2014 | 1315 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2018 | 2533 | 0.070 |
Why?
|
| Heart Ventricles | 1 | 2019 | 3800 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2017 | 3424 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 4647 | 0.070 |
Why?
|
| Gastroesophageal Reflux | 1 | 2011 | 717 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2013 | 41198 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 11145 | 0.060 |
Why?
|
| Disease-Free Survival | 3 | 2019 | 7015 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2014 | 4152 | 0.060 |
Why?
|
| Sulfonamides | 1 | 2012 | 1923 | 0.060 |
Why?
|
| Pancreatectomy | 2 | 2018 | 824 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 2720 | 0.060 |
Why?
|
| Synaptophysin | 1 | 2022 | 139 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2018 | 6664 | 0.060 |
Why?
|
| Epigenomics | 1 | 2017 | 806 | 0.060 |
Why?
|
| Risk Factors | 4 | 2017 | 70866 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2022 | 95 | 0.050 |
Why?
|
| Skin Diseases | 1 | 2010 | 1066 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 4194 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2011 | 4312 | 0.050 |
Why?
|
| Radiation | 1 | 2020 | 52 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 2025 | 0.050 |
Why?
|
| Chromosome Deletion | 2 | 2017 | 1373 | 0.050 |
Why?
|
| Neurofibrosarcoma | 1 | 2020 | 22 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 19537 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10620 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2017 | 2758 | 0.050 |
Why?
|
| Germ-Line Mutation | 2 | 2018 | 1727 | 0.050 |
Why?
|
| Incidence | 1 | 2018 | 20731 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2012 | 2930 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 3 | 1 | 2019 | 17 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 17409 | 0.050 |
Why?
|
| Cyst Fluid | 1 | 2019 | 68 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2014 | 21797 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 4455 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2014 | 9030 | 0.040 |
Why?
|
| Genotype | 1 | 2013 | 12919 | 0.040 |
Why?
|
| Carcinoma, Ductal | 1 | 2019 | 106 | 0.040 |
Why?
|
| Cardiomyopathies | 1 | 2010 | 1834 | 0.040 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2019 | 344 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2011 | 2256 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2018 | 4296 | 0.040 |
Why?
|
| T-Box Domain Proteins | 1 | 2019 | 475 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2017 | 308 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 10605 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2019 | 72443 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 5412 | 0.040 |
Why?
|
| Neurofibromin 1 | 1 | 2017 | 203 | 0.030 |
Why?
|
| Japan | 1 | 2019 | 1341 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2015 | 210 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2018 | 779 | 0.030 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2015 | 115 | 0.030 |
Why?
|
| Actins | 1 | 2022 | 2167 | 0.030 |
Why?
|
| Metaplasia | 1 | 2015 | 311 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 622 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2015 | 256 | 0.030 |
Why?
|
| Genome, Human | 1 | 2017 | 4471 | 0.030 |
Why?
|
| Lymphatic System | 1 | 2015 | 258 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2014 | 138 | 0.030 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2017 | 502 | 0.030 |
Why?
|
| Formaldehyde | 1 | 2015 | 365 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2018 | 580 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2010 | 6270 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2014 | 348 | 0.030 |
Why?
|
| Data Mining | 1 | 2018 | 552 | 0.030 |
Why?
|
| Time Factors | 1 | 2015 | 40875 | 0.030 |
Why?
|
| Tumor Virus Infections | 1 | 2015 | 455 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 515 | 0.030 |
Why?
|
| Europe | 1 | 2019 | 3343 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2017 | 1059 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2014 | 546 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2012 | 317 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2018 | 1801 | 0.030 |
Why?
|
| Phenotype | 2 | 2019 | 16311 | 0.030 |
Why?
|
| Chromatin | 1 | 2022 | 2686 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2014 | 778 | 0.030 |
Why?
|
| Indazoles | 1 | 2012 | 291 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 1571 | 0.020 |
Why?
|
| Rectum | 1 | 2015 | 883 | 0.020 |
Why?
|
| DNA Primers | 1 | 2015 | 2979 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3054 | 0.020 |
Why?
|
| Mastectomy | 1 | 2019 | 1702 | 0.020 |
Why?
|
| Neuroendocrine Tumors | 1 | 2015 | 532 | 0.020 |
Why?
|
| Epithelium | 1 | 2015 | 1721 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2017 | 1606 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 1834 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 6274 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1699 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 2015 | 1139 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 11940 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2017 | 2993 | 0.020 |
Why?
|
| DNA Repair | 1 | 2018 | 2034 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 34430 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 2129 | 0.020 |
Why?
|
| Fetus | 1 | 2015 | 1853 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2012 | 1879 | 0.020 |
Why?
|
| Panic Disorder | 1 | 2010 | 621 | 0.020 |
Why?
|
| Syncope | 1 | 2010 | 434 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 3770 | 0.020 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 1582 | 0.020 |
Why?
|
| Computational Biology | 1 | 2018 | 3571 | 0.020 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2010 | 869 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8890 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 1974 | 0.010 |
Why?
|
| Patient Selection | 1 | 2015 | 4293 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 18199 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 12456 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11655 | 0.010 |
Why?
|
| Tachycardia, Ventricular | 1 | 2010 | 1214 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 3493 | 0.010 |
Why?
|
| Palliative Care | 1 | 2015 | 3286 | 0.010 |
Why?
|
| Alcoholism | 1 | 2010 | 1859 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2010 | 2144 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2012 | 3350 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 1996 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2010 | 4410 | 0.010 |
Why?
|
| Echocardiography | 1 | 2010 | 5044 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2010 | 6386 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39300 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 80375 | 0.010 |
Why?
|
| United States | 1 | 2019 | 67905 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 6289 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 169420 | 0.010 |
Why?
|
| Obesity | 1 | 2010 | 12248 | 0.010 |
Why?
|